The Revolizer is a novel DPI device, which has been designed and developed to address the critical requirements of an ideal inhalation device. It provides accurate dosing and excellent lung deposition even at low inspiratory flow rates and is very easy to use and maintain.
For chronic obstructive airway diseases like asthma and COPD, administering medications through inhalation route is an efficient form of drug delivery. The key aspects of an ideal drug delivery system are- ease of use, reproducible dosing with optimal drug deposition, a feedback mechanism to ensure correct dosing, require minimal maintenance and must be environmentally friendly.
Two important factors to be considered while prescribing any inhaler to the patient are- ease of use and patient preference. Confidence and satisfaction with the inhaler device can help improve patient acceptance towards the device and the therapy, thus improving the treatment outcomes and reducing the healthcare costs
Dry powder inhalers (DPIs) are one of the most preferred inhalation drug delivery systems. Their advantages of being breath-actuated, easy to use, and compact make the DPIs reasonably well accepted by patients and their prescribers. Revolizer® is a novel unit dose DPI device having adequate drug deposition and a simple inhalation technique, allowing patients to confirm dose delivery as they can see, hear, and taste the drug.